Avacta Group (AVCT) Competitors

Avacta Group (LON:AVCT) and Silence Therapeutics (LON:SLN) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, media sentiment, earnings, community ranking, risk, institutional ownership and valuation.

Do insiders and institutionals have more ownership in AVCT or SLN?

10.1% of Avacta Group shares are owned by institutional investors. 32.9% of Avacta Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Does the MarketBeat Community prefer AVCT or SLN?

Avacta Group received 9 more outperform votes than Silence Therapeutics when rated by MarketBeat users. However, 68.81% of users gave Silence Therapeutics an outperform vote while only 67.30% of users gave Avacta Group an outperform vote.

Company	Underperform	Outperform
Avacta Group	Outperform Votes 212 67.30%	Underperform Votes 103 32.70%
Silence Therapeutics	Outperform Votes 203 68.81%	Underperform Votes 92 31.19%

Do analysts rate AVCT or SLN?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avacta Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Silence Therapeutics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Which has stronger valuation and earnings, AVCT or SLN?

Silence Therapeutics has lower revenue, but higher earnings than Avacta Group. Avacta Group is trading at a lower price-to-earnings ratio than Silence Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avacta Group	£23.25M	7.58	-£24.95M	-£0.09	-550.00
Silence Therapeutics	£11.35M	42.34	N/A	-£48.60	-11.01

Is AVCT or SLN more profitable?

Silence Therapeutics has a net margin of 0.00% compared to Avacta Group's net margin of -107.31%. Silence Therapeutics' return on equity of 0.00% beat Avacta Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avacta Group	-107.31%	-116.58%	-20.10%
Silence Therapeutics	N/A	N/A	N/A

Does the media prefer AVCT or SLN?

In the previous week, Avacta Group had 4 more articles in the media than Silence Therapeutics. MarketBeat recorded 5 mentions for Avacta Group and 1 mentions for Silence Therapeutics. Silence Therapeutics' average media sentiment score of 0.00 beat Avacta Group's score of -0.19 indicating that Silence Therapeutics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avacta Group	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Silence Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Silence Therapeutics beats Avacta Group on 7 of the 13 factors compared between the two stocks.